Language:
Password reminder
No account yet? Register Free
About Us Advertising Info Contact Us Client Login
labmedica.com
Hematology
Features Subscription Partner Sites Journal Info
SANYO EUROPE LTDTHE BINDING SITERANDOX LABORATORIES

Factor Xa-Based Antithrombin Assay Evaluated

By Labmedica International staff writers
Posted on 15 Nov 2011


A recently introduced antithrombin assay based on Factor Xa (FXa) has been evaluated on four different analyzers.

The INNOVANCE Antithrombin test is a new FXa-based chromogenic assay for automated quantification of functionally active anti-thrombin (AT) on coagulation analyzers.

Scientists working at Siemens Healthcare Diagnostic Products GmbH (Marburg, Germany) collaborated with investigators from the UK, Italy and another institution in Germany. They used clinical surplus plasma samples from 225 patients and 151 apparently healthy individuals from four different study sites to assay antithrombin.

The Siemens' INNOVANCE Antithrombin assay demonstrated on all analyzers repeatability coefficients of variation (CVs) ≤ 3.2% and within-device and between-run CVs ≤ 6.9%. The reference intervals of all analyzers are comparable with 2.5th percentiles between 80% and 85% of normal. The Siemens' INNOVANCE Antithrombin and the Factor IIa-based BerichromAT III (A) methods demonstrated good concordance with very high correlation coefficients.

The INNOVANCE Antithrombin method exhibited an excellent comparability with the STA Antithrombin III assay (Diagnostica Stago; Asnières sur Seine, France) and an acceptable comparability with the Coamatic LR Antithrombin assay (Instrumentation Laboratory, Bedford, MA, USA). The 31 patients with congenital deficiency were identified with all assays except for the patients carrying the P41L heparin-binding site mutation, which was only identified with the INNOVANCE Antithrombin and the STA Antithrombin III methods.

The authors concluded that this multicenter study demonstrates that the INNOVANCE antithrombin assay is precise and reliable to aid in the diagnosis of antithrombin deficiency. The advantages of this assay compared to the other methods were the higher sensitivity for heparin-binding site mutations, the liquid ready-to-use reagents, and the absence of interference by direct thrombin inhibitors. The study was published in October 2011, in the journal International Journal of Laboratory Hematology.

Related Links:
Siemens Healthcare Diagnostic Products
Diagnostica Stago
Instrumentation Laboratory




Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
Free digital version edition of LabMedica International sent by email on regular basis
Free print version of LabMedica International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of LabMedica International in digital format
Free LabMedica International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?

ADVERTISEMENT
GLOBETECH PUBLISHING



Electronic Pipettes
Electronic Pipettes
POCT Test
POCT Test
Face Shield
Face Shield

More Products

CELLAVISION AB
AACC

Latest Hematology News

LinkXpress
Click for LinkXpress
Reader Inquiry Service
Enter code to receive information:
Where I can find code?
Featured Whitepaper
ELGA LABWATER:
ELGA ensures largest latam lab is working night and day

Download Whitepaper
VISION-SCIENCES, INC.
Events
Journals of Clinical Laboratory update
23 Jun 2012 - 24 Jun 2012


FIME 2012 – Florida International Medical Exhibition.
08 Aug 2012 - 10 Aug 2012


ECI - European Congress of Immunology
05 Sep 2012 - 08 Sep 2012


More events
Latest Issue

View Digital Edition
Subscribe / Renew
GREINER-BIO-ONE'
BioPorto Diagnostics
EUROIMMUN AG
BRAND GMBH + CO
INOVA DIAGNOSTICS INC
GLOBETECH PUBLISHING
PURITAN MEDICAL
  labmedica.com Copyright © 2000-2012 Globetech Media. All rights reserved.
Privacy Policy